Scientists have identified two molecules that could help treat leukemia, in a way that’s far less damaging to healthy cells than existing chemotherapy. The compounds work using a different mechanism ...
GLP-1 drugs are predicted to become the top-selling pharmaceutical class ever, with projected US sales of $150 billion by 2030. I have written multiple articles on GLP-1 drugs, highlighting their ...
Researchers looked specifically at head-to-head randomized clinical trials of next-in-class cancer drugs against existing agents in the same class. Less than one-quarter of next-in-class cancer drugs ...
The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their arsenal for treating drug-resistant infections. Researchers have now discovered ...
Please provide your email address to receive an email when new articles are posted on . Most of the studies compared TNF inhibitors with non-TNF-inhibitor DMARDs. The results may indicate that ...
GUILFORD, Conn. & SHANGHAI, China--(BUSINESS WIRE)--Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a ...
Coverage of key CVD medications in low-cost generic drug programs in the United States differs by plan, medication type, and condition, according to an analysis published recently online in Annals of ...
What's Next?', ITV News meets families and teens impacted by the drug as the debate over whether to make it a Class A continues.
Despite rising medicine expenditures driven by expensive innovative therapies, the financial burden on patients in Belgium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results